Efficacy of anlotinib plus immune checkpoint inhibitors in soft-tissue sarcoma: systematic review and meta-analysis
- DOI
- 10.1080/14796694.2026.2730089
- Published
- 2026-09-19
- Container
- Future Oncology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2026.2730089,
title = {Efficacy of anlotinib plus immune checkpoint inhibitors in soft-tissue sarcoma: systematic review and meta-analysis},
author = {Ahmed Farid Gadelmawla and Ahmed A. Abo Elnaga and Abdullah Faisal Albukhari and Raseel B. Almutairi and Basmah Alamri and Sami Mohammed Alhuways and Fatemah Althaher and Flwah Aloufi and Abdullah Mohammed A. Alotaibi and Abdullah Alali and Ali Almatri and Hamad Althawadi and Abdullah Altamimi},
year = {2026},
journal = {Future Oncology},
doi = {10.1080/14796694.2026.2730089},
url = {https://doi.org/10.1080/14796694.2026.2730089}
}RIS
TY - JOUR TI - Efficacy of anlotinib plus immune checkpoint inhibitors in soft-tissue sarcoma: systematic review and meta-analysis AU - Ahmed Farid Gadelmawla AU - Ahmed A. Abo Elnaga AU - Abdullah Faisal Albukhari AU - Raseel B. Almutairi AU - Basmah Alamri AU - Sami Mohammed Alhuways AU - Fatemah Althaher AU - Flwah Aloufi AU - Abdullah Mohammed A. Alotaibi AU - Abdullah Alali AU - Ali Almatri AU - Hamad Althawadi AU - Abdullah Altamimi PY - 2026 JO - Future Oncology DO - 10.1080/14796694.2026.2730089 UR - https://doi.org/10.1080/14796694.2026.2730089 ER -
APA
Gadelmawla, A. F., Elnaga, A. A. A., Albukhari, A. F., Almutairi, R. B., Alamri, B., Alhuways, S. M., Althaher, F., Aloufi, F., Alotaibi, A. M. A., Alali, A., Almatri, A., Althawadi, H., & Altamimi, A. (2026). Efficacy of anlotinib plus immune checkpoint inhibitors in soft-tissue sarcoma: systematic review and meta-analysis. Future Oncology. https://doi.org/10.1080/14796694.2026.2730089
Source records
- crossref · retrieved 2026-09-26T13:35:58.020Z